Powered by 
All the sales intelligence you need on ICON Plc in one solution.
Register your interest Learn more
- Save hours of research time with a comprehensive
Sales Intelligence Solution. - Understand how ICON Plc fits into your total
addressable market and Ideal Customer Profile. - Gain competitive edge with triggers that tell you
when and how to engage with ICON Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
- Overview
- Segment Analysis
- Financials
- Executives
- SWOT Analysis
- Locations
- Competitors
- Deals
- Filing Analytics
- Patents
- Theme Exposure
- Media
- Premium Data
- Clinical Trials
- Catalyst Calendar
- Lead Sheet
- Investigators
- Insights
- Marketed Drugs
ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. The company provides specialized services that span the entire lifecycle of product development. ICON’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, and women’s health, among others. ICON is headquartered in Dublin, Ireland.
Gain a 360-degree view of ICON Plc and make more informed decisions for your business Gain a 360-degree view of ICON Plc and make more informed decisions for your business Learn more
Headquarters Ireland
Address South County Business Park, Leopardstown, Dublin 18, 00000
Website www.iconplc.com
Telephone 353 1 2912000
No of Employees 41,100
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ICLR (NASD)
Revenue (2022) $8.1B 4.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 21.2% (2022 vs 2021)
Market Cap* $24.8B
Net Profit Margin (2022) XYZ 15.5% (2022 vs 2021)
* As of and is in US$
View ICON Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more
ICON Plc premium industry data and analytics
1,500+
Clinical Trials
Determine ICON Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
1,000+
Catalyst Calendar
Proactively evaluate ICON Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
430+
Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for ICON Plc’s relevant decision makers and contact details.
220+
Investigators
Review investigator profiles and find information on trial contacts across ICON Plc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.
100+
Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
5
Marketed Drugs
Understand ICON Plc’s commercialized product portfolio to stay one step ahead of the market.
1
IT Client Prospector provides intelligence on ICON Plc’s likely spend across technology areas enabling you to understand the digital strategy.
Products and Services
| Services |
|---|
| Adaptive Trials |
| Laboratory Services |
| Medical Imaging Services |
| XYZ |
| XYZ |
| XYZ |
Understand ICON Plc portfolio and identify potential areas for collaboration Understand ICON Plc portfolio and identify potential areas for collaboration Learn more
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Others | In February, the company advised flexis on its acquisition by Blue Yonder. |
| 2024 | Acquisitions/Mergers/Takeovers | In February, the company acquired HumanFirst. |
| 2024 | Acquisitions/Mergers/Takeovers | In February, the company completed the acquisition of Clinical Research Management Inc. |
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Competitor Comparison
| Key Parameters | ICON Plc | Thermo Fisher Scientific Inc | IQVIA Holdings Inc | Laboratory Corp of America Holdings | Syneos Health Inc |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | United States of America | United States of America | United States of America |
| City | Dublin | Waltham | Durham | Burlington | Morrisville |
| State/Province | Dublin | Massachusetts | North Carolina | North Carolina | North Carolina |
| No. of Employees | 41,100 | 122,000 | 88,000 | 67,000 | 28,768 |
| Entity Type | Public | Public | Public | Public | Private |
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Key Financial Charts
Sales Growth
Net Income Growth
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ciaran Murray | Chairman; Director | Executive Board | 2017 | 61 |
| Steve Cutler Ph.D | Director; Chief Executive Officer | Executive Board | 2017 | 63 |
| Brendan Brennan | Chief Financial Officer | Senior Management | 2012 | 45 |
| Thomas O'Leary | Chief Information Officer | Senior Management | 2013 | - |
| Diarmaid Cunningham | Secretary; General Counsel; Chief Administrative Officer | Senior Management | 2016 | 49 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Gain insight into ICON Plc key executives to enhance your sales strategy Gain insight into ICON Plc key executives to enhance your sales strategy Learn more
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
